Viewing Study NCT00301951


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2025-12-25 @ 9:37 PM
Study NCT ID: NCT00301951
Status: COMPLETED
Last Update Posted: 2017-10-12
First Post: 2006-03-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
Sponsor: University of California, San Francisco
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module